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Clinical / Scientific note
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Delayed cerebral ischemia is an important cause of 
poor outcome in patients with aneurysmal subarachnoid 
hemorrhage (SAH). This clinical syndrome is caused by a 
critical reduction of cerebral blood flow brought on by a 
pathologic luminal narrowing of the cerebral arteries af-
ter SAH (vasospasm)1. It usually presents within 12 days 
after SAH and its pathogenesis probably depends upon 
inflammatory mechanisms. Its occurrence after 15 days 
is quite uncommon. Late diagnosis is often difficult and 
many times overlooked. Considering the role of triple H 
therapy in the treatment, differential diagnosis acquires 
paramount importance. 
We present a rare case of extremely delayed cerebral 
vasospam after SAH.
CaSE
A 43 years-old female attended to the emergency room (ER) 
complaining of sudden, intense headache. Neurological exam-
ination disclosed meningismus. She was alert, presenting score 
15 in the Glasgow Coma Scale. Head CT revealed a Fischer grade 
III SAH (Fig 1). Angiogram depicted an anterior communicating 
artery aneurysm, without signs of radiological vasoespasm (Fig 
2). Aneurysm clipping was uneventfully performed three days 
after SAH, without need for temporary clipping. Postoperative 
Fig 1. Axial head CT scan depicting a subarachnoid hemorrhage Fisher grade III.
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CT scan did not reveal abnormalities. There was no clinical va-
sospasm during the first twenty-one days of SAH, and patient 
was neurologically intact when discharged. 
After 45 days, she returned to the ER presenting a left-sided 
hemiparesis. CT scan revealed a capsular ischemic area on the 
right cerebral hemisphere (Fig 3). No antecedents of hyperten-
sion and diabetes were observed. Arterial pressure levels were 
normal at admission. Serum levels of glucose and cholesterol 
were normal. Cardiac ultrasonography revealed no abnormali-
ties as well as carotid and vertebral ultrasonography. Transcrani-
al doppler (TCD) ultrasonography disclosed higher flow veloci-
ties suggestive of vasospasm. Triple H therapy was installed and 
patient completely recovered. Clinical improvement coincides 
with normalization of the TCD initial findings. Patient was dis-
charged clinically intact.
diSCuSSion
Symptomatic vasospasm has been reported in 22% to 
40% of patients suffering SAH and leads to high rates of 
morbidity (34%) and mortality (30%)2. The diagnosis of 
vasospasm is based upon clinical findings and evidence 
of luminal narrowing on angiogram or flow alterations on 
TDU3,4. Angiographic evidence of arterial spasm is seen in 
up to 70% of patients, and clinical manifestations are wit-
nessed in 20 to 30% of patients5,6. Despite the introduc-
tion of nimodipine and the use of induced hypertension, 
symptomatic vasospasm still remains the major cause of 
morbidity and mortality in patients with SAH7-11. 
Symptomatic vasospasm is defined by clinical crite-
ria such as: 1) symptoms occurring between days 5 and 12 
after SAH, including headache, stiff neck, low-grade fe-
ver, insidious confusion, decline in level of consciousness 
and focal neurological deficit; 2) a head CT scan excluding 
other causes of worsening; and 3) no other identifiable 
cause of neurological deterioration8,9. Vasospasm can oc-
cur within 30 days after SAH, and clinical vasospasm after 
one month aneurysm bleeding is extremely rare and may 
difficult differential diagnosis. The case of patient who 
presented clinical deterioration after 45 days of SAH con-
firmed by TCD and clinical response to spasm therapy. In 
the present case, the age of the patient, absence of risk 
factors, normal carotid, vertebral and cardiac ultrasonog-
raphy, associated with the TCD findings, coupled with the 
clinical improvement after triple H therapy and normal-
ization of the TCD, practically excludes other causes of 
ischemic damage (embolism, aterothrombosis, etc) points 
to the vasospasm as the causal factor. 
Delayed cerebral vasospasm, which is the most critical 
clinical complication that occurs after SAH, seems to be 
Fig 2. Left internal carotid artery angiogram showing an anterior communicating artery aneurysm.
Fig 3. Capsular area of ischemia in the right cerebral hemisphere.
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associated with both impaired dilator and increased con-
strictor mechanisms in cerebral arteries3-8,10-13. Mechanisms 
contributing to development of vasospasm and abnormal 
reactivity of cerebral arteries after SAH have been inten-
sively investigated in recent years10-13. The studies in the 
pathogenesis of vasospasm have focused on the inflam-
matory response after SAH, which may play a relevant 
role in its development and maintenance3,4, secondary to 
a sudden abnormal contact of the extraluminal walls of 
arteries with all of the components of blood5. The inflam-
matory factors induced by SAH seem to be a great factor 
causing arterial spasm.
In the instance of SAH, a complex series of cellular 
and molecular events is elicited by the presence of blood 
clot in the subarachnoid space, culminating in a robust 
inflammatory response. Erythrocytes are dissolved, releas-
ing oxyhemoglobin, which diffuses through the arterial 
wall of the endothelium13. A cascade of inflammation oc-
curs, including infiltration and activation and recruitment 
of leukocytes, cytokine production, immunoglobulin and 
complement activation, and transcription factor activa-
tion, resulting in prolonged smooth muscle contraction 
and arterial spasm13. These processes are auto-limited in 
the majority of the cases, however, delayed manifesta-
tions may occur. 
It is possible that the mass effect of a large hematoma 
remaining in the sylvian fissure and an intracerebral he-
matoma after surgery may justify delayed development 
of spasm in some cases. Nonetheless, in the current case 
there was no hematoma left to explain late vasospasm. 
It is possible that the continuous inflammatory disease 
could bring to a progressive nip of brain arteries, and this 
was only revealed later in the course. 
In conclusion, even though a very rare occurrence, ex-
tremely delayed vasospasm may occur after the first month 
after SAH. The neurological follow-up should be judicious 
and include frequent medical consultation in the first two 
months. Its occurrence must always be considered in the 
differential diagnosis of late neurological deterioration.
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